IRF6 and multiple sclerosis: The results were subsequently confirmed in an independent cohort study of patients with multiple sclerosis in which liver injury was proved with significantly increased aspartate aminotransferase and alkaline phosphatase concentrations for those who carried IRF6 genetic variants (Kowalec et al., 2018; Takahashi et al., 2020).